fda bpc 157 category 2 bulk drug substances compounding list Industry Update: Interim 503A and 503B Bulks Lists New Revisions An FDA advisory committee voted

An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Pharmacy Purchasing & Products Magazine

SKU: 95772559484 · From swgunbroken.com